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All models are wrong, but some are useful! 
 
George Edward Pelham Box.  
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ABSTRACT 
During evolution a variety of solutions has been developed by different living 
organisms in order to protect itself from invading potential pathogens and particles. 
Protection of the host is essential for its survival and involves efficient recognition and 
elimination of potential pathogens. The recognition is often mediated by pathogen 
recognition receptors (PRRs). Activation of PRRs is mainly driven by exogenous 
pathogen associated molecular patterns (PAMPs) or endogenous danger associated 
molecular patterns (DAMPs) and result in secretion of multiple pro-inflammatory 
cytokines. Toll-like receptors (TLRs) are members of the PRR family and the 
importance of these receptors during pro-inflammatory conditions is addressed in the 
present thesis, both in vitro and in vivo.  
 
In Paper I we showed that farmers and smokers, two groups that are continuously 
exposed to organic material through daily work at the farm or through tobacco smoke, 
have an ongoing inflammation in the respiratory tract. It was shown that chronically 
exposed subjects develop an adaptation to the effects of acute exposure to inhaled 
organic material. Further, it was demonstrated that exposure in the swine barn was a 
much stronger pro-inflammatory stimulus than inhaled pure lipopolysaccharide (LPS), 
in vivo.  
 
In Paper II, the gene expression of TLR2 on primary bronchial epithelial cells was 
demonstrated. This expression was synergistically enhanced by co-stimulation with 
pro-inflammatory stimuli and glucocorticosteroids. Dust obtained from the swine barn 
was a more potent pro-inflammatory stimulus than pure LPS or pure peptidoglycan 
(PGN), in vitro, as already shown in vivo. The secreted pro-inflammatory cytokines 
from the epithelial cells were diminished by blocking of the TLR2 and TLR4 with 
monoclonal antibodies, indicating that the pro-inflammatory stimulation was at least 
partly dependent on TLR2 and TLR4. 
 
In paper III we found that TLR2 on blood neutrophils was down-regulated by pro-
inflammatory stimuli, whereas the expression TLR4 and CD14 were unaffected by the 
pro-inflammatory stimulation, in vitro. The expression of TLR4 and CD14 were 
increased by the presence of epithelial cells, irrespective of stimulation. Moreover, we 
showed synergistically enhanced secretion of CXCL8 (IL-8) and sCD14 during co-
culture compared to single culture condition and a strong positive correlation between 
CXCL8 and sCD14 in LPS-stimulated co-cultured cells. These findings strongly 
suggest an active bidirectional cross-talk between alveolar epithelial cells and 
neutrophils.  
 
In paper IV we confirmed what we already had shown in vitro, that TLR2 was down 
regulated by pro-inflammatory conditions on neutrophils, this time in vivo. We also 
showed the presence of soluble TLR2 (sTLR2) in BAL and sputum and that this 
expression was altered in COPD compared to healthy subjects. Moreover, CD14 
expression on sputum neutrophils was enhanced compared with blood neutrophils and 
that the gene expression of CD14 on alveolar macrophages in BAL-fluid was increased 
in smokers compared with non-smokers. These findings indicate that PRRs expression 
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is altered by smoking per se, but also that the disease, COPD, contributes. This is likely 
of importance in COPD patho-physiology, in particular for exacerbations, which often 
are caused by microorganisms.  
 
Overall, these studies have shown the involvement of PRRs in several immunological 
active cell types during pro-inflammatory conditions. A better understanding of the 
mechanisms behind PRRs regulation and outcome would potentially benefit drug 
development and in the end many patients with inflammatory diseases.  
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1 INTRODUCTION 
 
It has been known for centuries that our lungs are influenced by the air we breathe. In 
1555 the Danish bishop Olaus Magnus warned about the dangers of inhaling grain dust. 
He suggested that: “In separating the grain from the chaff, care most be taken to choose 
a time when there is a suitable wind which will sweep away the grain dust, so that it 
will not damage the vital organs of the threshers” (1).  
 
Rural living conditions are declining due to the urbanization of both developing and 
western countries. One consequence of these changes is that less people are exposed to 
the farming environment. The growing industrialization will, however, lead to 
increased air pollution which implies increased regular human exposure to inhalable 
potential pathogens. These factors will likely influence global health. 
 
This thesis focuses on two groups with high airway exposure to environmental agents; 
farmers who work in a highly contaminated environment and smokers who are exposed 
to a mixture of airborne particles in the inhaled tobacco smoke.  
 
 
1.1 THE RESPIRATORY SYSTEM 
Depending on the physical activity, an adult person breathes 10-20 m3 of air each day. 
During inhalation the air passes through the nasal cavity down into the bronchial tree 
and ending up in the alveolar ducts and alveolar sacs where the gas exchange takes 
place.  
 
Inhalation of air allows deposition of particles and microorganisms on the surface of 
the respiratory tract, an ideal environment for bacterial growth. Airflow, pharyngeal 
anatomy and the size of the particle are factors that affect the level of particle 
deposition in the respiratory tree. It is common to distinguish between inhalable and 
respirable particles, where inhalable particles are < 10µm and respirable particles are 
<5µm.  
 
The ciliated epithelial cells, lining the respiratory tract, represent the first line of 
defence in the lungs and function as a mechanical barrier. Synchronized beating cilia 
works in viscous fluid where inhaled foreign particles get trapped. Mucus and particles 
are then transported towards pharynx by the coordinated beating of the cilia. This 
mucociliary clearance is one of the mechanisms that keeps the lower respiratory tract 
clean and prevent mucus accumulation in the lungs. Infections, tobacco smoke and 
pollutants reduce mucociliary clearance and increase the risk of recurrent respiratory 
infections. In the alveolar ducts the ciliated epithelium is replaced by non-ciliated 
epithelium with direct contact with the capillaries. Airway epithelial cells are 
multifunctional cells that serve as a barrier, but are also providing the host with an 
inflammatory response to threatening organisms by release of pro-inflammatory 
cytokines and chemokines (2).  
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The next line of defence of the host is the phagocytes. Alveolar macrophages are found 
peripherally of the lungs and together with neutrophils they provide the host with innate 
protection of the respiratory tract by identification and phagocytosis of foreign particles 
(3).  
 
 
1.2 INFLAMMATION  
Inflammation constitutes a defense against invading organisms and contributes to 
healing of wounds and infections. The cells and mediators involved in the immune 
response are powerful, which makes it critical to regulate the intensity and the duration 
of the inflammatory response, thereby diminishing potential harmful effects. 
 
 
1.2.1 Acute inflammation  
Acute inflammation is the initial response to harmful stimuli and consists of increased 
number of leukocytes, mainly granulocytes, which have been migrating from the 
bloodstream to the “site of action”. This will result in the five cardinal signs of 
inflammation; dolor (pain), calor (heat), rubor (redness), tumor (swelling) and functio 
laesa (loss of function). The players of the acute inflammation are rather short-lived and 
the acute inflammation requires constant stimulation to be sustained. An active 
termination of the inflammation is needed to prevent unnecessary tissue damage (4). 
 
The working environment has potential health influences, e.g. among farmers whose 
daily work involves respiratory health hazards, due to exposure to airborne particulate 
material, organic dust. The content of the dust is heterogeneous and contains high 
amounts of pathogen-associated molecular patterns (PAMPs) such as fungi, endotoxins 
and peptidoglycans. The main contents of the dust obtained from the swine 
confinement buildings are microorganisms, animal dander, urine and feces (5). 
Inhalable dust and endotoxin concentrations up to 28.5 mg/m3 and 1.2µg/m3, 
respectively, have been reported (6, 7). 
  
Organic dust is a potent pro-inflammatory stimulus. After a few hours of exposure in 
the swine confinement building healthy, naïve, non-allergic volunteers develop 
increased bronchial responsiveness, intense airway inflammation, dominated by 
neutrophils and increased levels of pro-inflammatory cytokines (IL-1β, IL-6, CXCL8 
(IL-8) and TNF) in BAL-fluid (7, 8) and IL-6 and CXCL8 (IL-8) in sputum and NAL 
(9). Increased pro-inflammatory cytokines in serum (10) demonstrate that the reaction 
involves systemic engagement, often called organic dust toxic syndrome (ODTS) with 
flu-like symptoms such as fever, chills, malaise, headache, dyspnea and muscle pain 
(11). These symptoms (ODTS) normally disappear within 24 hours after exposure.     
Farmers who are exposed to this highly contaminated environment on a daily basis 
develop inflammatory and physiological attenuated responses to acute exposure when 
compared with healthy non-farmers (12). It has also been shown that farmers, despite 
lack of respiratory symptoms, have an ongoing lower respiratory tract inflammation, 
with increased numbers of inflammatory cells and elevated CXCL8 in BAL and 
sputum (9, 13). It is intriguing that children who grow up on farms have lower 
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prevalence of asthma, hay fever and allergy than children who grow up in urban areas 
(14, 15). 
 
 
1.2.2 Chronic inflammation  
Neutrophils are one of the first immuno-active cell types to arrive to the site of injury. 
A persistent acute inflammation may lead to a progressive shift in the type of cells at 
the site of injury. In general, chronic inflammation is often dominated by mononuclear 
cells, such as monocytes and lymphocytes, whereas in asthma by eosinophils. 
However, in severe asthma as well as in COPD, the dominating cell type is neutrophils.    
 
1.2.2.1 Chronic bronchitis in farmers 
As most farmers live on the farm where they work, they are continuously exposed to 
the farming environment and potential pathogens derived from organic dust. Farmers 
have an increased risk of respiratory morbidity, such as chronic bronchitis (16) and the 
duration of farming is associated with reduction in lung function (17).  
 
Chronic obstructive pulmonary disease (COPD) 
Tobacco smoking is the most common cause of COPD, but other types of exposure e.g. 
occupational exposure may be of relevance. Miners and tunnel workers, and never-
smoking animal farmers have increased prevalence of COPD (5, 18-21). The 
prevalence of COPD has increased and is expected to be the third most common cause 
of death by 2020 (22, 23)  
 
Chronic obstructive pulmonary disease is a condition which is characterized by 
irreversible airway obstruction caused by small airway disease (obstructive 
bronchiolitis) and parenchymal destruction (emphysema).  
 
The severity classification of COPD into four stages is based on spirometry data (table 
1)   
 
Spirometric classification of COPD severity(23) 
All stages of COPD has a FEV1/FVC<0.70 
Stage I: mild FEV1≥ 80% predicted 
Stage II: moderate 50%≤FEV1<80% predicted 
Stage III: severe 30%≤FEV1<50% predicted 
Stage IV: very severe FEV1<30% predicted or FEV1 <50% 
predicted plus certain negative prognostic 
factors. * 
Table 1 The GOLD guidelines.  
FEV1 : forced expiratory volume in one second, FVC : forced vital capacity 
* arterial partial pressure of O2 less than 8.0 kPa with or without arterial partial pressure of CO2 > 
6.7 kPa, BMI < 22, mucus hypersecretion.  All lung function values are obtained after 
bronchodilatation. 
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The chronic inflammatory process in the lungs involves several cell types and 
neutrophils, macrophages, eosinophils, T-lymphocytes (especially CD8+) are reported 
to be increased in numbers in COPD-patients (24). 
COPD is associated with systemic inflammation, inflammatory markers including 
CRP, leptin, IL-6, CXCL-8, IL-1β and TNF-α, among others, are elevated in plasma 
from COPD-patients (25). 
Co-morbidities are frequent in COPD-patients and are unfortunately, often 
undiagnosed. The prevalence of heart failure, lung cancer, depression and diabetes 
mellitus type II are increased in COPD, compared to the population in general (23, 26). 
    
COPD is a chronic disease with irreversible destruction of the lungs. The over all aim 
of COPD treatment is to relieve the symptoms, slowing the progress of the disease and 
to prevent exacerbations. In all stages of the disease, from mild to very severe COPD, 
physiotherapy plays an important role in the treatment of the patient. Patients with 
COPD usually benefit from treatment with bronchodilators such as anticholinergics and 
β2-agonists. Frequent exacerbations contribute to the decline in lung function, impaired 
quality of life and increased mortality in patients with moderate and severe COPD (27-
29). Therefore it is important to reduce the exacerbation rate in COPD-patients. 
Pharmacotherapy with long acting β2-agonist and glucocorticosteroid in combination as 
well as treatment with roflumilast reduce the rate of exacerbations (30-32). 
Anticholinergic therapy has also been shown to have positive effects on the rate of 
exacerbation, hospitalization and mortality in patients with moderate to very severe 
COPD, but not on the rate of decline in FEV1(33, 34).          
 
Smoking cessation is however the only measure that conclusively alters the negative 
trend of a rapid decline in FEV1, which is connected to the progression of the disease.  
 
 
1.3 THE IMMUNE SYSTEM 
The immune system is a collection of both cellular and humoral component and its 
most important role is to discriminate between self and non-self. Traditionally the 
immune system is divided into innate and adaptive immune system. The innate immune 
system operates in all plants and animals; it is fast, fixed and effective in stopping most 
microbial threats at an early stage. The adaptive immune system is slowly activated, but 
powerful and highly specific in the mode of action. It is only present in vertebrates and 
is often induced by the innate immune system. The adaptive immune system is an 
evolving process within the lifetime of the host and is rapidly reactivated on future 
challenge with the same pathogen (35, 36). 
 
 
1.3.1 Innate immune system 
Already at birth the innate immune system provides a non-specific immediate defense 
against potential pathogens. The innate immune system has no immunological memory, 
implying that this system does not confer long-lasting immunity against pathogens.  
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Major functions of the human innate immune system are: 
 
1. Identification and removal of potential pathogens accomplished by specialized 
leukocytes (white blood cells). 
2. Recruiting other immune cells to the site of action by producing cytokines and 
chemokines. 
3. Activation of the complement cascade, identifying bacteria and promote 
clearance of dead cells. 
4. Activation of the adaptive immune system, through antigen presentation. 
    
 
1.3.1.1 Cells participating in the defense of the organism 
Different specialized cell types are involved in the protection of the host. Epithelial 
cells (EpC) are lining the respiratory tract and serve as the host first line of defense. The 
epithelial phenotype differs depending on localization and function. Thus, bronchial 
epithelial cells, alveolar type I and type II epithelial cells do not just constitute a 
physical barrier but are also active in the recognition of potential pathogens and hold an 
immunological response by release of several pro-inflammatory cytokines. Moreover, 
the ciliated bronchial epithelium is responsible for mucociliary clearance helping the 
lower respiratory tract to stay clean.  
 
Monocytes (macrophages), neutrophils, dendritic cells, basophils, eosinophils, mast 
cells and lymphocytes, collectively known as leucocytes lack the ability of reproduction 
and are products of a multipotent hematopoetic stem cell, produced in the bone 
marrow. They are not associated with a specific organ but patrol the organism using the 
bloodstream as their main highway.  
 
Alveolar macrophages are derived from blood monocytes and are multifunctional cells, 
highly involved in the defense of the airways. Phagocytosis of cell debris and foreign 
particles is one of the main functions, which is also orchestrating the immune response 
and function between innate and adaptive immune system. They are also producers of 
the pro-inflammatory cytokine TNF-α and CXCL8, an important chemoattractant for 
neutrophil granulocytes. The neutrophils, eosinophils and basophiles form together a 
family of granulated polymorphonuclear cells. The neutrophils are the most abundant 
type of white blood cells and are normally found in the blood stream. During the acute 
phase of inflammation neutrophils are migrating in large numbers to the site of injury. 
Neutrophils engulf and kill extracellular pathogen through release of an assortment of 
proteins during degranulation; a process with the main purpose to destroy invading 
microorganisms. The mast cells also have the ability to degranulate and release their 
histamine rich granule, they are distributed in tissues that are exposed to the external 
environment and are associated with allergy and anaphylaxis. Dendritic cells (DCs) are 
professional antigen presenting cells with a branched dendritic morphology. They serve 
as a bridge between the innate and the adaptive immunity, through stimulation of T-cell 
responses. Lymphocytes are divided into small (T-cells and B-cells) and large (natural-
killer cells, NK-cells). T-cells and B-cells are both members of the adaptive immune 
system. T-cells are involved in the cell-mediated defense of the host, whereas the B-
cells are antibody producing cells and play a key role in the humoral immunity. NK-
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cells are part of the innate immune system and have the ability to distinguish between 
infected cells and “normal” cells and destroys/kills altered cells (36, 37). 
 
 
1.3.2 Pattern Recognition Receptors 
In 1989 Janeway suggested “that the actual detection of infection was mediated by the 
receptors of the innate immune system, rather than the antigen receptors” which later 
were called pattern recognition receptors (PRRs) (38). The PRRs are evolutionary 
conserved proteins that are divided into different classes: Toll-like receptors (TLRs), 
nucleotide binding and oligomerization domain-like receptors (NOD or NLRs) and 
retinoic acid-inducible gene 1-like receptors (RLRs). PRRs are expressed by non-
immune and immune cells and can be differentially localized within the cells, both 
membrane bound and cytoplasmic PRRs occur (39). These receptors make it possible 
for the cell to identify pathogen-associated molecular patterns (PAMPs), which 
together with the endogenous alarmines, which are associated with cellular stress or 
death, form a larger category termed: damage associated molecular patterns (DAMPs) 
(40).   
 
Toll-like receptors (TLRs) are type I  transmembrane glycoproteins and consist of an 
extracellular leucine-rich repeat (LRRs) domain, the transmembrane domain and a 
cytoplasmic TIR-domain (Toll-IL-1 receptor). Toll-receptors were first discovered in 
Drosophila melanogaster, the first human homologue was reported in 1997 by Janeway 
and Medzhitov (41), and was consequently called Toll-like receptor. Since then, 
another ten human TLRs have been identified (TLR1-TLR11) (42). Each TLR 
recognizes specific PAMPs and exists in homo- and heterodimers, which increase the 
diversity of receptor specificity. TLR signaling can be classified as either MyD88- or 
TRIF-dependent pathways, both lead to induction of pro-inflammatory cytokines, but 
the TRIF-dependent pathway also leads to type I interferon response (42). Toll-like 
receptors have been considered to have a key-role in the discrimination between “self” 
and “non-self”, which is indispensable for a functional defense of the human body. 
 
 
1.3.2.1 TLR2  
Toll-like receptor 2 (TLR2) is located on the cell surface and has the capability to 
recognize a wide range of ligands such as Gram-positive bacteria, cell wall components 
like LTA (lipoteichoic acid), peptidoglucan and lipoproteins. The great variation of 
ligands is at least partially explained by the ability of TLR2 to form heterodimers with 
TLR1 or TLR6 (42). Not only exogenous ligands bind to TLR2. During stress or injury 
endogenous derived ligands, induce sterile inflammatory responses through TLR 
interaction. Heat-shock proteins (HSP) and high mobility group box-1 (HMGB1) are 
both examples of host derived proteins that interact with TLR2. The broad role and the 
potential of the endogenous ligands in a variety of pathological processes are still 
unclear (40, 42, 43).  Signaling through the TLR2 pathway is MyD88 dependent and 
will lead to activation of NF-κB and subsequently to release of various pro-
inflammatory cytokines and chemokines.  
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Up to six different isoforms of soluble toll-like receptor 2 (sTLR2) are present in 
human plasma, breast milk, saliva, BAL fluid and sputum (44, 45). It is believed that 
sTLR2 establishes a regulatory function as a decoy receptor during inflammation (46). 
 
 
1.3.2.2 TLR4 
Toll-like receptor 4 (TLR4) was one of the first TLRs to be identified and are also one 
of the most extensively studied. TLR4 forms a complex together with MD2 on the cell 
surface serving as the main LPS (Lipopolysaccharide) binding component (47). LPS 
are one of the major constituent of the outer membrane of Gram-negative bacteria. An 
additional protein that also is involved in the TLR4-signaling pathway is LPS-binding 
protein (LBP). LBP is present in plasma and binds LPS and CD14. The LPS-LBP 
complex is delivered to the receptor TLR4-MD2. TLR4 is the only TLR that activates 
both the MyD88- and TRIF-dependent pathway, which is the reason why stimulation of 
the TLR4-pathway may lead to both early and late NF-κB activation as well as release 
of type I interferons.  
 
The response to LPS exposure is dependent on the presence of CD14, but also whether 
LPS is designated as rough or smooth (rLPS, sLPS). LPS classification as smooth or 
rough depends of the presence of an O-polysaccaride chain, if the LPS molecule has the 
O-polysaccharide chain it is classified as sLPS otherwise as rLPS. This affects the 
colony morphology of the LPS. The CD14-independent pathway can only bind rLPS 
and is limited to the MyD88-dependent pathway, resulting in activation of NF-κB and 
transcription of TNF, IL-6, CXCL8 etc. In presence of CD14 the TLR4-MD2 complex 
binds both rLPS and sLPS. This complex does not only signal through the MyD88-
dependent pathway but also through TRAM and TRIF, leading to IRF-3 activation and 
IFN-β transcription (48, 49). 
Several endogenous ligands of TLR4 have been identified, most of them associated 
with cell damage and tissue injury, such as HSPs (Heat-shock proteins) and HMGB1 
(High mobility group box 1). The soluble form of TLR4 (sTLR4) has been shown to 
function in mice as an antagonists to LPS-stimulation, inhibiting the binding of the 
ligand to the membrane bound receptor, serving as an important regulator of the innate 
immune response of the host (50). Soluble TLR4 mRNA has been found in human. 
Naturally occurring sTLR4 has been detected in human saliva and four different 
polypeptides of sTLR4 has been shown to be up-regulated during chronic inflammation 
of the oral mucosa. The largest of these forms suppress LPS activation in THP-1 cells 
(51, 52).  
 
 
1.3.2.3 CD14 
In 1990, almost a decade before the first Toll-like receptor was characterized. CD14 
was the first PRR to be discovered (53). CD14 was first identified as a differentiation 
marker on the surface of monocytes and macrophages, but later on it became clear that 
CD14 together with LBP play an important role in binding of LPS. CD14 is expressed 
in a soluble form (sCD14) in plasma, sputum, BAL fluid etc. and is regarded as an 
acute phase protein (54). The LPS/LBP/CD14 complex binds to TLR4 which leads to 
pro-inflammatory cytokine production. The sCD14 are known to mediate LPS-
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activation in cells with low expression of CD14, such as epithelial cells. However, at 
high concentrations of LPS, sCD14 are also known to function as a decoy receptor and 
thereby downregulate the LPS induced response. It has also been shown that CD14 
contributes to amplified response of other TLRs, than TLR4, e.g. TLR2 (55, 56).  
The level of sCD14 increases in plasma during infection and inflammation and are 
elevated in BAL fluid from smokers. A strong correlation between neutrophil numbers, 
total protein and sCD14 are found in BAL fluid, indicating that CD14 are an important 
player in the complex system of inflammation in the lungs (57, 58).  
 
 
Figure 1 TLR2 and TLR4 signaling pathways; transmembrane and intracellular Toll-like receptor 
regulators 
 
 
1.3.3 Regulatory mechanisms of Toll-like receptors 
Toll-like receptor signaling is essential for a functional defense of the host against 
invading microorganisms and pathogens. Since it was discovered that Toll-like 
receptors not just respond to exogenous ligands but also endogenous ligands produced 
as a result of tissue damage, it has been an emerging interest of studies focusing on 
Toll-like receptors and chronic inflammation.  
 
On one hand TLRs serves as regulators of the innate and adaptive immune responses 
and, on the other, excessive activation of the TLR signaling pathway have been 
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implicated in the development of several severe diseases such as sepsis, atherosclerosis, 
diabetes mellitus, rheumatoid arthritis, inflammatory bowel disease, asthma and COPD 
(59-61). Additionally, it has previously been shown that continuously exposed farmers 
have an ongoing inflammation in the respiratory tract and higher prevalence of chronic 
bronchitis than the population in general (17, 62). Recent findings have shown 
attenuated TLR2 expression on circulation blood monocytes in farmers compared to 
smokers and healthy controls, indicating systemic effects dependent of the exposure 
(63). In common for many of these diseases is the initiation of chronic inflammatory 
condition.  
 
A tight negative regulation of TLR signaling and function seems to be crucial and 
several regulatory levels occurs. Soluble receptors (TLRs, CD14) have a first line of 
negative regulatory function as extracellular decoy receptors. Next level of regulating 
mechanisms is the transmembrane regulating proteins (SIGIRR, ST2L), but also 
degradation, deubiquitination and competition (SOCS, MyD88s) are general 
intracellular regulating mechanisms that all are present in the regulation of TLR 
signaling (51, 61, 64, 65). The field focusing on negative regulatory mechanism of TLR 
are growing fast and new therapeutics based on TLR activation are already in 
development were as some have progressed to clinical trials (66). 
 
 
1.3.4 Pro-inflammatory cytokines and chemokines 
The complex actions of cytokines are the host response to harmful exposure (infection 
and disease) and serve as regulators via receptor interactions. Cytokines are generally 
divided into two major groups’ pro- or anti-inflammatory cytokines depending on the 
biological activities (67). Cytokines have a variety of functions and may signal in many 
different ways: Endocrine signaling, will affects target cells on a distance from the 
secreting cell. Hormones are a typical example of this kind of signaling, but also 
cytokines can act this way (IL-6, IL-1, TNF-α). Paracrine-signaling, affects cells that 
are near the cytokine secreting cell (IL-1, TNF-α) and autocrine-signaling cytokines 
affects the same cell that secreted the cytokine (IL-2). Chemokines such as CXCL8 
(IL-8) function as a guide for migration of inflammatory cells to the site of action and 
are thereby important mediators during inflammation.   
 
Signaling through toll-like receptors leads to transcription, translation and release of 
pro-inflammatory cytokines. Some of them are briefly described below: 
 
IL-1β is secreted by multiple cell types but mainly by monocytes/macrophages. IL-1β 
activates the vascular endothelium and lymphocytes. It mediates local tissue destruction 
and increases the access of effector cells. Systemic effects derived by IL-1β are fever 
and increased production of IL-6.   
 
IL-6 is secreted by multiple cell types but mainly by monocytes/macrophages and 
epithelial cells. IL-6 plays an important role in mediating fever, acute phase reactions 
and activates lymphocytes to increase antibody production. It has mainly pro-
inflammatory properties but possess also anti-inflammatory capacity.  
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CXCL8 (IL-8) is a member of the chemokine family. It is potent activator and 
chemoattractant for neutrophils, but also for T-cells, basophils and eosinophils.  
Macrophages, neutrophils and epithelial cells are the main producers. 
 
TNF-α (Tumor necrosis factor alpha) is produced by a wide variety of immune cell 
types and epithelial cells. It promotes inflammatory responses and is a key-cytokine in 
many inflammatory disorders. TNF-α binds to at least two receptors, TNF-receptor 1 
and 2 (TNFR1 and TNFR2). More or less all cell types express TNFR1, whereas 
TNFR2 expression is limited to hematopoetic cells. 
 
Interferons (IFN) are divided into two subgroups; type 1 and type 2, according to their 
receptor specificity and sequence homology. IFN-α/β is type 1 interferons and is 
expressed by almost all cell types and is early components of the immune activation, 
mainly induced by virus. IFN-α/β induces dendritic cell maturation, cytotoxicity of 
natural killer cells, promote half life of activated T-cells and stimulate B-cell 
differentiation into anti-body-producing plasma cells.  
 
IFN-γ, the only type 2 interferon, has immuno-stimulatory and an immuno-regulatory 
effect such as, increasing antigen presentation and lysosome activity in macrophages, 
suppression of Th2 cell activity and promotion of leukocyte migration. IFN-γ is mainly 
produced by NK-cells, Th1-cells, cytotoxic T-cells and dendritic cells. Aberrant IFN-γ 
production is associated with a number of autoimmune diseases (36, 68). 
 
 
1.4 GLUCOCORTICOSTEROIDS 
In 1950 the Nobel Prize in Medicine and Physiology was awarded to Kendall and 
Reichstein, for isolation and synthetisation of cortisol and adrenocorticotropic hormone 
(ACTH), which later on was developed and improved to be the glucocorticosteroids 
used today. Glucocorticosteroids are used in the treatment of inflammatory and 
immune diseases and are among the most widely used drug in the world. 
Glucocorticosteroids cross the cell membrane, into the cytoplasm, were it binds to the 
intracellular glucocorticoid receptor (GR). The predominant effect of 
glucocorticosteroids is to switch of multiple inflammatory genes encoding for pro-
inflammatory cytokines and chemokines, such as IL-6, CXCL8 and TNF-α, 
counteracting some of the important inflammatory features (69). Glucocorticoids and 
the bronchodilating β2-agonists are often given together in asthma and COPD, two 
disorders characterized by chronic inflammation in the airways and lungs. A potential 
beneficial effect of the steroids is its ability to modulate the effect and function of β2-
receptors thereby possible preventing tolerance development induced by β2-agonists 
(70). The mechanisms of glucocorticosteroids are complex, and not completely 
understood. In 2004 Homma et. al. proposed another function of glucocorticosteroids in 
airway inflammatory disorders, as they, showed that TLR2 was upregulated by 
glucocorticosteroids in stimulated respiratory epithelial cells in vitro (71).   
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2 AIMS OF THE STUDY 
 
The general objective of these studies was to elucidate how pattern recognition 
receptors, with focus on TLR2, TLR4 and CD14, are affected during inflammation in 
the lungs. The specific aims were: 
 
• To elucidate whether chronic exposure to organic material on a daily basis 
(smokers and farmers) alters physiological and inflammatory responses to acute 
exposure to organic material. 
 
• To study the regulation of TLR2 and TLR4 in primary bronchial epithelial cells 
during pro-inflammatory conditions, and to explore possible effect of the 
interaction between glucocorticosteroids and these receptors. 
 
• To elucidate if there is an active cross-talk between neutrophils and alveolar 
epithelial cells, regarding pattern recognition receptors (PRRs) and if this cross-
talk is altered in COPD. 
 
• To characterize the expression of PRRs and their soluble form on/from 
immuno-active cells from different compartments, in patients with chronic 
inflammation (COPD) as well as in smokers and non-smokers.  
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3 MATERIAL AND METHODS 
The following section contains a brief description of the methods used. Detailed 
information is found in each publication and manuscripts.  
 
 
3.1 MATERIAL 
 
3.1.1 Human study population 
All subjects gave informed consent and the studies were approved by the ethics 
committee of Karolinska Institutet. 
 
Controls 
All controls were non-smokers, had normal lung function and no airway hyper-
responsiveness. None had a history of asthma or allergy and had no other chronic 
diseases. (Paper I, III, IV)   
 
Farmers 
Farmers were included in the study if they had been exposed in the pig barn on a daily 
basis for the past 6 month. (Paper I) 
 
Smokers without COPD 
The smokers without COPD had normal lung function (FVC>80% of predicted value) 
with post-bronchodilator FEV1/FVC > 0.70 and had no history of allergy or asthma. 
The smokers without COPD were in age matched with farmers, (Paper I) and matched 
with regard to age and pack-years with COPD-patients. (Paper IV) 
 
COPD 
All subjects with COPD had a post-bronchodilator FEV1/FVC < 0.70 and FEV1 of 40-
70 % of predicted value and arterial oxygen saturation (SaO2) > 90%. All were current 
smokers. (Paper III, IV) 
 
 
3.1.2 Exposures (In vivo) 
The experimental design of the exposure in a pig confinement building and exposure to 
pure LPS is described below (Figure 2). The pig house exposure lasted for three hours 
while weighing pigs. The LPS (53.4µg) exposure was performed by inhalation of six 
breaths of a LPS-solution in saline (E. Coli 0111:B4) using an inhalation dosimeter, 
(SPIRA® Elektro 2), corresponding to 53.4µg LPS. FEV1 was measured before, 30 
min and 60 min after, and then every hour for 6 hours after the provocation. The 
subjects were exposed in randomized order, with a three weeks period between the 
exposures. 
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Figure 2, Experimental design and measured parameters (paper I) 
 
 
Lung function and bronchial responsiveness were measured before and 7 hours after 
the start of each exposure. (Paper I) 
 
 
3.1.3 Sample collection and processing 
 
Lung function and bronchial responsiveness 
Vital Capacity (VC) and FEV1 were measured using a wedge spirometer according to 
ATS guidelines (72). PEF was measured with a peak flow meter (mini-Wright®). 
(Paper I) 
 
Inhalation of doubling concentrations of methacholine up to 32 mg/ml (starting at 0.5 
mg/ml) was used to test bronchial responsiveness. The result was expressed as the 
cumulative dose causing a 20% decrease in FEV1 (PD20FEV1) (73). (Paper I) 
 
Exhaled nitric oxide (NO) 
Nitric oxide in exhaled air was measured during a single-breath exhalation, with a flow 
rate of 50mL/s, according to ATS guidelines (74). (Paper I) 
 
• Skin prick test# 
• NAL* 
• Lung function test 
• Exhaled NO 
• Bronchial responsiveness 
• Induced sputum 
• Symptoms, body temperature, PEF; before 
exposure and every hour until 7 hours after 
#
 only visit 1 
*not after LPS challenge 
VISIT 1 
2 weeks 
PIG BARN 
LPS PIG BARN 
LPS 
≥3 weeks 
Healthy controls, n=12 
Tobacco smokers, n=12 
Farmers, n=11 
≥3 weeks 
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Skin-prick test 
Skin-prick test were performed on the forearms of each subject using a panel of 10 
common allergens, with histamine chloride as a positive control. (Paper I) 
 
Respiratory and inhalable dust measurement 
Inhalable dust sampler (IOM) and plastic cyclones were used to monitor inhalable and 
respirable dust levels, respectively. The samplers were placed in the breathing zone on 
two subjects at each exposure occasion. (Paper I) 
 
Nasal lavage (NAL) 
Sterile 0.9% NaCl (5ml) was instilled into one nostril and 10 seconds later, expelled 
and collected and then repeated in the other nostril. The samples from the two nostrils 
were pooled and centrifuged, the cells were then counted in a Bürker chamber and the 
supernatant was stored in -70º C until further analysis. (Paper I) 
 
Sputum induction and processing 
After inhalation of salbutamol (0.4mg) sputum was induced by inhalation of saline in 
increasing concentrations, starting at 0.9%, using an ultrasonic nebulizer. Each 
concentration was followed by FEV1 measurement. The subject made then an attempt 
to expectorate sputum. A sample that macroscopically appeared to be free from saliva 
and had a weight > 1g was accepted. The sputum sample was processed with 
dithiothreitol, filtered and centrifuged. The supernatant was stored in -70º C until 
further analysis. The cell pellet was resuspended and cell concentration, viability and 
differential cell counts were isolated. (Paper I, IV) 
 
Bronchial lavage fluid (BAL) 
Bronchoscopy was performed after pre-medication with morphine or pethidine and 
scopolamine and local anesthesia with xylocain® during the procedure. The 
bronchoscope was wedged in a middle lobe segmental bronchus and isotonic saline (5 x 
50ml), was instilled into the airway tree and gently sucked back. The lavage fluid was 
centrifuged and the supernatant was stored in -70º C until analysis. The cell pellet was 
resuspended and the cells were cultured ex vivo. (Paper IV) 
 
Blood sampling 
Peripheral blood was collected in ethylene diamine-tetra-acetic acid (EDTA) vacutainer 
tubes for assessing cell surface markers using flow cytometry (FACS). (Paper IV) 
 
For isolation of blood neutrophils, blood was drawn into heparineized tubes. (Paper III) 
 
Symptoms 
General and airway specific symptoms were recorded before and after exposure on a 
visual analogue scale 0–100 mm. The subjects were requested to put a cross on a scale 
where 0 indicated none, while 100 indicated unbearable symptoms. (Paper I) 
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3.1.4 Cell-culture procedures and experiments (in vitro) 
 
Culture of Primary bronchial epithelial cells (PBEC) 
Primary bronchial epithelial cells (PBEC) that had been established from patients who 
underwent thoracic surgery (lobectomy) were cultured as previously described (75). 
The cells were provided with Keratinocyte Serum-Free Medium (KSFM, Gibco, UK) 
that was supplemented with epidermal growth factor (EGF, 5 ng/ml, Gibco, UK), 
bovine pituitary extract (BPE, 50 µg/ml, Gibco, UK), pen/strep every second day. Test 
for Mycoplasma contamination (SVA, Uppsala, Sweden), were tested negative and in 
order to distinguish epithelial origin of the cells, immunostaining for cytokeratin was 
performed and was tested positive. (Paper II)  
 
A549 
The human alveolar epithelial type II cell line A549 was purchased from ATCC 
(American Type Culture Collection, Rockville USA). The cells were cultured in cell-
culture flasks and provided with HAM’s F-12 cell media supplemented with 
penicillin/streptomycin (1%) and heat inactivated fetal calf serum (10%) every second 
day. At confluence the cells were detached by trypsin/EDTA and re-cultured. Passages 
6-10 were used in the cell experiments. (Paper III) 
 
Neutrophils, isolation and cell culture 
Whole blood was mixed with an equal volume of PBS-Dextrane (2%), and left for 
sedimentation. The leukocyte containing dextrane-blood was gently put on top of an 
equal volume of lymphoprep  (Lymfoprep®) and then centrifuged. The cell pellet was 
then resuspended in PBS, washed and the red blood cells were lysed with distilled 
water. The neutrophils were washed twice with D-PBS and resuspended in RPMI 
supplemented with fetal calf serum (10%), L-glutamin (1%) and 
penicillin/streptomycin (1%). Cell concentration and viability were established with 
Türc solution and trypan blue, respectively and calculated in a Bürker chamber. (Paper 
III) 
 
Co-culture of A549 and neutrophils 
Freshly isolated neutrophils were added to cell-culture inserts with underlying A549 
cells in the bottom of the 24-well plate. The cell culture experiments were preformed in 
supplemented RPMI. (Paper III)  
 
Alveolar macrophages 
The cells obtained from BAL-fluid were seeded and after two hours the macrophages 
were presumed to be adhered. The supernatant was discarded and PBS was added to the 
macrophages in order to perform mRNA preparation. (Paper IV) 
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3.2 METHODS 
 
3.2.1 Analysis of mRNA 
 
mRNA preparation and Real-time PCR 
Preparation of mRNA was performed from primary bronchial epithelial cells (Paper II) 
and from alveolar macrophages (Paper IV). Total mRNA was isolated by PureLink™ 
Micro-to Midi Total RNA Purification System. DNase I, amplification grade was used 
to remove genomic DNA. First-strand cDNA was synthesized from 0.5µg of total 
RNA. Real-time PCR was performed using an ABI Power SYBR Green Master mix, 
1µl of cDNA was amplified in 25µl PCR reaction to identify the products of interest. 
Beta-actin or GAPDH was used as internal control genes. The primers (beta-actin, 
GAPDH, IL-6, IL-8, TLR2, TLR4, CD14) were exon-exon spanning and designed 
using the software Primer3.  
Data were analyzed using 7500 Software v.2.0.1, the results were then calculated and 
expressed as 2-∆Ct. 
 
 
3.2.2 Analysis of proteins  
 
Flow cytometry 
To analyze cell distribution in peripherial blood a four color antibody mixture 
(CD3FITC/CD8PE/CD45PerCp/CD4APC) was used in TrueCOUNT™ tubes. 
 
Flow cytometry has also been used to identify and quantify surface markers (TLR2, 
TLR4 and CD14) on blood neutrophils (Paper III, IV) and sputum neutrophils and 
blood monocytes (Paper IV). The cells were incubated with monoclonal fluorochrome 
conjugated or matched isotype antibodies for 30 minutes, washed and analyzed using 
FACSCalibur ™ flow cytometry and CELLQuest ™. Data are presented as relative 
median fluorescence intensity (rMFI : monoclonalantibody / matched isotype control). 
(Paper III, IV) 
 
 
ELISA 
IL-6 and CXCL8 (IL-8) 
Interleukin-6 and CXCL8 (IL-8) have been measured in the supernatants from NAL, 
sputum and cell-culture experiments using an in-house ELISA method. Commercially 
available antibody pairs were used (76). (Paper I, II, III) 
 
sCD14 
Soluble CD14 (sCD14) has been measured in the supernatants from sputum, BAL fluid 
and cell-culture experiments using a purchased DuoSet ELISA CD14 kit. The analysis 
was performed according to the manufactures protocol. (Paper III, IV) 
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sTLR2 
Soluble Toll-like receptor 2 (sTLR2) has been measured in the supernatants from BAL 
and sputum with a purchased DuoSet ELISA sTLR2 kit. The analysis was performed 
according to the manufactures protocol. (Paper IV) 
 
Endotoxin measurement 
Endotoxin concentration was analyzed using a kinetic technique version of Limulus 
amebocyte lysate assay (Limulus Amebocyte lysate, Endosafe® Endochrome-KTM U.S. 
Lisence No. 1197), with E. coli 0111:B4 as standard. (Paper I, IV) 
 
 
3.3 STATISTICS 
Data are presented as scatters with median, with 25th-75th percentile, as mean ± SEM 
(standard error of the mean) or as 95% confidence intervals, depending on the 
distribution of the data.  
 
When data was normally distributed, parametric test, such as, ANOVA for repeated 
measurements followed by paired t-test (within group comparisons) and ANOVA 
followed by Fisher’s PLSD (between-group comparisons) were used.  
 
When data was considered not to be normally distributed, non-parametric analyze 
methods were used. Within group comparisons were performed using Friedman’s test 
(if more than two groups) followed by Wilcoxon signed rank-sum test as post hoc test. 
Between-group comparisons were analyzed by Kruskal-Wallis if more than two 
groups, followed by Mann-Whitney U-test as a post hoc test.  
 
All data were analyzed by Statview version 5.0.1 (SAS Institute Inc., Cary NC). A 
value of P<0.05 was considered significant.  
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4 RESULTS 
P-values are not stated in the text, but can be found in the figures and/or in the 
corresponding captions. 
 
 
4.1 PAPER I  
REPEATED EXPOSURE TO ORGANIC MATERIAL ALTERS 
INFLAMMATORY AND PHYSIOLOGICAL AIRWAY RESPONSES 
 
The aim of this study was to find out whether the response to inhalation of organic dust 
and lipopolysaccharide (LPS) is altered in chronically exposed individuals i.e. smokers 
and farmers.  
 
Baseline FEV1 measurement were significantly lower in farmers and smokers 
compared to controls (data not shown).  
 
The control subjects significantly decreased in VC and FEV1 after pure LPS exposure. 
No such effect was observed in the continuously exposed groups, farmers and smokers. 
No significant changes in lung-function post-exposure compared to pre-exposure 
values were found between the three groups (controls, farmers, smokers). (Table 2) 
 
 
 
Table 2, Changes in lung function after exposure to dust or pure LPS  
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Figure 3, Bronchial responsiveness to methacholine, (as measured by the cumulative dose causing a 
20% decrease in FEV1 (PD20)). At baseline (●), after LPS challenge (∆) and after exposure in the 
swine barn (■). Horizontal lines indicates medians. P-values for within group comparisons are as 
follows: #P=0.01, ¶P=0.02, +P=0.003, §P=0.04, ***P<0.001. Pre-exposure and post LPS-exposure 
PD20 did no significantly differ between the groups.  After exposure to the swine house bronchial 
responsiveness increased to a greater extent in controls compared to farmers and smokers P<0.001. 
 
Interleukin-6 (IL-6) and CXCL8 (IL-8) were measured in the supernatants from NAL 
(Figure 4) and sputum (Figure 5). 
 
 
 
 
Figure 4, Concentration of IL-6 (a) and CXCL8 (IL-8) (b) in nasal lavage. At baseline (●) and after 
exposure in the swine barn (■). Horizontal lines indicates medians. P-values for within group 
comparisons are as follows: #P=0.002 and ¶P=0.004.  No significant differences were observed in 
the baseline between the groups. After swine barn exposure: no differences between the groups 
regarding IL-6, whereas CXCL8 (IL-8) increased significantly less in farmers compared to the 
other groups. 
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Figure 5, Concentration of IL-6 (a) and CXCL8 (IL-8) (b) in sputum supernatants.  At baseline (●), 
after LPS challenge (∆) and after exposure in the swine barn (■). Horizontal lines indicates 
medians. P-values for within group comparisons are as follows: #P=0.003, ¶P=0.05,  +P=0.008, 
§P=0.005, ƒP=0.002, ##P=0.02, ¶¶P=0.006, ++P0.01 and §§P=0.03.  At baseline were IL-6 elevated 
in smokers compared to controls and CXCL8 (IL-8) were higher in both smokers and farmers 
compared to controls.  
 
To conclude, we found that the two continuously exposed groups to organic material 
i.e. farmers and smokers have signs of an ongoing airway inflammation in the central 
but not in the upper airways. Smokers seem to have an increased response to LPS-
exposure, compared to both farmers and controls, regarding pro-inflammatory 
cytokines in sputum (IL-6, IL-8). We also found that exposure in the swine barn was a 
much stronger pro-inflammatory stimulus than inhalation of pure LPS.   
The most important finding was that the response to exposure in a swine barn differed 
between the groups. Both physiological outcomes like bronchial responsiveness, but 
also markers of airway inflammation like exhaled NO and pro-inflammatory cytokines 
were attenuated in farmers compared to controls.  
 
 
4.2 PAPER II  
BUDESONIDE ENHANCES TOLL-LIKE RECEPTOR 2 EXPRESSION IN 
ACTIVATED BRONCHIAL EPITHELIAL CELLS 
 
The aim of this study was to elucidate if Toll-like receptor (TLR) 2 and TLR4 
expression were altered by exogenous and/or endogenous pro-inflammatory stimuli and 
to what extent glucocorticosteroids alter TLR expression. The experiments were 
preformed on primary bronchial epithelial cells (PBEC). The mRNA expression and 
the released amount of the pro-inflammatory cytokines interleukin-6 (IL-6) and 
CXCL8 (IL-8) were measured and regarded as outcome variables. 
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Figure 6, Stimulation of PBEC with dust, LPS, TNF with or without budesonide. mRNA 
expression (A, B) and secreted protein (C, D) of IL-6 and IL-8 respectively. IL-6 and IL-8 were 
measured after 1.5 hours (open circles) and 6 hours (filled circles). Data are presented as medians 
and interquartile ranges. #p<0.05 compared with the unstimulated control and *p<0.05 compared 
with the corresponding budesonide treated sample.   
 
 
We found that the mRNA expression and release of IL-6 and IL-8 were increased by 
pro-inflammatory stimuli. This increase in cytokine secretion was reduced by 
budesonide both after endogenous and exogenous stimulation (Figure 6).  
 
To elucidate if pro-inflammatory stimulation and/or glucocorticosteroids alter TLR2 
expression, TLR2 mRNA was measured 6 hours after pro-inflammatory exposure with 
or without budesonide.   
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TLR2 mRNA was synergistically increased after 6 hours exposure to all tested pro-
inflammatory stimulus only in the presence of a glucocorticosteroid (Figure 7). 
 
Finally, we performed blocking experiments of TLR2 and/or TLR4 with antibodies to 
elucidate to what extent the released IL-6 and IL-8 was a result of ligand binding to 
TLR2 and TLR4.  
 
 
 
 
 
 
Figure 7, Expression of TLR2 mRNA after 6 hours exposure of pro-
inflammatory stimuli, with or without budesonide. Data are presented as 
medians and interquartile ranges.  
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In general, blocking of TLR2 and/or TLR4 with monoclonal antibodies resulted in a 
greater inhibition of CXCL8 (IL-8) release than IL-6 release.  A statistically significant 
blocked release of CXCL8 (IL-8) was obtained in use of stimulation with specific 
TLR2 and TLR4 agonist, Pam3CSK4 and LPS, respectively. During dust stimulation 
both IL-6 and CXCL8 (IL-8) release was significantly inhibited by either of the two 
TLR-antibodies and in the combination of them with some additive effect (Figure 8). 
 
To conclude, IL-6 and CXCL8 (IL-8) released from stimulated bronchial epithelial 
cells are partly TLR2/4 dependent. TLR2 mRNA expression was increased and IL-6 
and IL-8 production reduced when budesonide was added to stimulated primary 
bronchial epithelial cells.  
 
Figure 8, PBEC cells unstimulated (A) or stimulated with Pam3CSK4 (B), LPS (C) or 
dust (D). Blocking of TLR2 and/or TLR4 followed by stimulation with corresponding 
ligand. Secreted IL-6 and IL-8 were measured in the supernatant. Open circles 
represent IL-6, filled circles IL-8. Data are presented as fold change of the 
corresponding control as medians and interquartile ranges. *P<0.05 **P<0.01 
compared to unstimulated control. Significant differences between treatments are 
indicated with brackets.  
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4.3 PAPER III  
INTERACTIONS BETWEEN ALVEOLAR EPITHELIAL CELLS AND 
NEUTROPHILS DURING PRO-INFLAMMATORY CONDITIONS 
 
In paper III, an active cross-talk between alveolar epithelial cells (A549) and 
neutrophils during normal and pro-inflammatory conditions was studied. We also 
wanted to find out if this possible cross-talk is altered in COPD. Neutrophils and A549 
cells were stimulated with TNF, PGN or LPS in single culture and during co-culture 
experiments. The neutrophils were obtained from subjects with or without COPD. 
 
After pro-inflammatory stimulation the expression of TLR2/4 and mCD14 on 
neutrophils were assessed with FACS. 
 
 
Figure 9, Cell surface expression of TLR2 (a), TLR4 (b) and mCD14 (c) in single and co-cultured 
neutrophils obtained from healthy non-smokers and smokers with COPD. Data are presented as 
mean±SEM. *P<0.05 **P<0.01 and ***P<0.001 compared to corresponding unstimulated control. 
Significant differences between single cultured and co-cultured neutrophils are indicated with 
brackets.  
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We found that TLR2 expression on the cell surface on neutrophils was down regulated 
by all tested pro-inflammatory stimuli. On the other hand, mCD14 was increased on the 
cell surface by co-culture conditions independent of pro-inflammatory or normal cell 
culture conditions (Figure 9). 
 
As outcome variable, CXCL8 (IL-8) was measured in the supernatant, together with the 
soluble form of CD14 (sCD14). 
 
 
 
 
Figure 10, Co-cultured neutrophils/A549 and summarized single cultured neutrophils + A549. 
Soluble CD14 (A) and CXCL8 (B) were measured in the supernatant. *P<0.05 **P<0.01 
***P<0.001. Regression plot of sCD14 and CXCL8 in LPS stimulated co-cultured neutrophils and 
A549 cells (c).  
 
We found that sCD14 and CXCL8 (IL-8) were synergistically enhanced during co-
culture conditions compared to summarized single culture cells. Irrespective of normal 
or pro-inflammatory conditions (Figure 10A, B). We also found a strong correlation 
between sCD14 and released CXCL8 (IL-8) in LPS-stimulated co-cultured cells 
(Figure 10C).  
 
To conclude we found an active cross-talk between alveolar epithelial cells and 
neutrophils, regarding regulation of pattern recognition receptors (PRRs) and one of 
their down-stream effector CXCL8 (IL-8). The cross-talk was observed both during 
normal and pro-inflammatory conditions. A strong correlation between sCD14 and 
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CXCL8 (IL-8) in LPS-stimulated co-cultured cells, indicate a bidirectional cross-talk 
were sCD14 are donated by neutrophils to epithelial cells facilitating LPS-signaling. 
This will subsequently lead to increased CXCL8 (IL-8), a potent chemo attractant for 
neutrophils, released by the alveolar epithelial cells. No statistical significant 
differences were observed between controls and COPD subjects. 
  
 
4.4 PAPER IV  
TOLL-LIKE RECEPTOR EXPRESSION IN SMOKERS WITH OR WITHOUT 
COPD 
 
In paper IV we wanted to elucidate if innate immune receptors are altered in smokers 
with or without COPD and if this possible alteration is present in circulating cells. 
Inflammatory cell expression of TLR2, TLR4 and CD14 and soluble TLR2 and CD14 
were assessed in blood, bronchoalveolar lavage fluid (peripheral airways) and induced 
sputum (central airways) from smokers with and without COPD and in healthy non-
smokers. 
 
 
 
Figure 11, TLR2 expression on blood and sputum neutrophils. Data obtained from the same 
subject are connected with a line. Significant differences between compartments are stated with a 
P-value and between groups with a bracket.  
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Figure 12, Soluble TLR2 (sTLR2) in BAL-fluid (A) and sputum (B) supernatants. Significant 
differences between groups are stated with a bracket and P-value.  
 
 
We found that TLR2 on the surface on neutrophils were down regulated on sputum 
neutrophils compared to blood neutrophils. This was only significant in smokers 
irrespective of airway obstruction (Figure 11). Further, COPD-patients express less 
TLR2 on their sputum neutrophils compared to non-smoking controls. In line with that 
finding sTLR2 was elevated in sputum supernatants in the COPD group compared to 
both healthy smokers and controls. In BAL-fluid sTLR2 was about a tenth of the 
concentration in sputum supernatants with the lowest concentration were found in the 
COPD-group (Figure 12). 
 
 
Figure 13, TLR4 expression on blood and sputum neutrophils. Data obtained from the same 
subject are connected with a line. Significant differences between compartments are stated with a 
P-value.  
 
BA
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We found that TLR4 expression on neutrophils was upregulated on sputum neutrophils 
compared to circulating neutrophils. This was only observed in the non-smoking 
control group. No significant differences between the groups were observed (Figure 
13).  
 
Figure 14, CD14 expression on blood and sputum neutrophils. Data obtained from the same 
subject are connected with a line. Significant differences between compartments are stated with a 
P-value. 
 
 
 
Figure 15, Gene expression of CD14 on alveolar macrophages. Significant differences between 
groups are stated with a P-value.  
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We found that CD14 are upregulated on sputum compared to blood neutrophils in 
smokers. No statistical significant differences were observed between the groups 
(Figure 14). We also found an increased gene expression of CD14 on alveolar 
macrophages obtained from smokers, irrespective of airway obstruction, compared to 
the control-groups (Figure 15). 
 
To conclude, our studies showed that different PRRs are differently regulated during 
pro-inflammatory conditions. Further, we found that PRRs expression is affected by 
tobacco smoking, but also by COPD per se, as we found differences between smokers 
with and without airway obstruction, but the same cumulative exposure to tobacco 
smoke. Moreover, we showed for the first time the presence of the soluble form of 
TLR2 (sTLR2) in sputum and BAL fluid supernatants. We hypothesize that PRRs are 
affected and might even be involved in the development of the chronic inflammatory 
disease.   
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Figure 16, Schematic overview of PRRs during pro-inflammatory conditions in the alveoli. 
TLR2
IL-6 
CXCL8 
TNFα
NEUTROPHILS
TLR2
MACROPHAGES
TLR2
PAMPs/DAMPs
ALVEOLAR 
EPITHELIAL CELLS
sCD14
?
TLR4/CD14
TLR4/CD14
TLR4/CD14
TLR4/CD14
sTLR2 ?
?
 38 
5 GENERAL DISCUSSION 
 
Continuous exposure to inhalable particles affects our immune system and our lungs.  
There are several characteristics of the exposure that determine the biological 
consequences, such as, the content, size and origin of the particles, the subject’s age 
and the duration of the exposure.   
 
The main objective of this thesis was to characterize the inflammatory airway response 
to chronic exposure of organic material. Therefore we studied farmers, who are 
exposed on a daily basis in their work environment, and smokers with and without 
chronic obstruction (COPD) exposed to organic material through tobacco smoke. The 
focus was on PRRs (Pattern Recognition Receptors), especially Toll-like receptors 
(TLR), and how they are regulated in immunologically active cell types as well as 
soluble receptors in different compartments in vivo and in vitro. 
 
Children who grow up on a farm or have parents who are active in the agricultural 
sector have a lower prevalence of asthma and allergy, than children who grew up in an 
urban environment (14, 77, 78). On the other hand, the adult farmers have a higher 
prevalence of respiratory diseases such as chronic bronchitis and reduced lung function 
than the population in general (17).  
 
However, children who grow up in the farming environment have an increased gene 
expression of TLR2, TLR4 and CD14 on circulating blood cells, and there is a positive 
correlation between the number of different animal species to which the mother was 
exposed to during pregnancy and the expression of these genes in the child. The same 
pattern of increased PRRs gene expression, although less pronounced are found in 
children exposed to the farm environment, in early life (79, 80). On the other hand, 
adult farmers have a reduced expression of TLR2 on circulating blood monocytes (63). 
The observed differences, with up-regulation of PRRs in young children and down 
regulation of PRRs in their parents, as an effect of daily exposure are intriguing. 
Importantly, these studies also demonstrate systemic effects of the chronic organic dust 
exposure. To summarize, it seems likely that the PRR expression on circulating cells 
are affected by the continuous exposure to organic dust and that these receptors are 
differently regulated in children and adults. This might be of importance for the 
outcome in the long run as the farmers have higher prevalence of chronic bronchitis and 
are also known to be colonized with bacteria in their airways. 
 
In paper I it was shown, that the farmers had elevated levels of exhaled nitric oxide 
(NO) and CXCL8 (IL-8) in the sputum supernatant, compared with a naïve control 
group. This indicates an ongoing inflammation in the respiratory tract. Acute exposure 
in the swine barn showed that farmers and smokers had an attenuated immune response 
compared with healthy controls. The control group showed a significantly greater 
increase in bronchial responsiveness compared with the chronically exposed groups 
(farmers and smokers) after three hours exposure in the swine barn. This suggests some 
kind of tolerance, in the chronically exposed groups, a finding that supports earlier 
results (12, 81, 82). It is possible that this tolerance is not beneficial in the long 
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perspective, but may cause disease development, such as chronic bronchitis later in life. 
Although, no significant differences were observed in bronchial responsiveness prior to 
exposure, it was clear that the exposed groups had a somewhat higher bronchial 
reactivity than the controls. It can not be excluded that the difference in bronchial 
responsiveness (PD20FEV1) after exposure in the swine barn between controls and 
chronically exposed (smokers/farmers) is due to the difference in baseline values. This 
means that, farmers and smokers had a somewhat increased bronchial responsiveness 
already at baseline, which may have resulted in less pronounced reduction of PD20FEV1 
after exposure in the swine barn. This has previously been shown to be of relevance 
(83).  
 
Susceptible individuals may have symptoms that make them more prone to leave the 
farming environment. This health-based selection process has been suggested to occur 
in swine farmers for asthma, but not for chronic bronchitis, as the symptoms often 
appear later in life (16). Farms are often inherited and stay within the family. This 
might lead to a more pronounced healthy-worker effect within the farming families, 
than in other occupations. There are studies showing several inherited active relevant 
polymorphisms in the receptor complex that binds Lipopolysaccharide (LPS), i.e. both 
TLR4 and CD14. These polymorphisms have been shown to affect both the 
inflammatory response as decrease in FEV1 (84-86). The polymorphisms in PRRs 
might be of relevance in the health-based selection process that occurs in farmers. 
 
Lipopolysaccharide (LPS) is just one out of many potent components in the farming 
environment. The organic dust found in the swine barns where we have exposed the 
subjects are highly heterogeneous and contains various microbial components from 
microorganisms, molds, yeast and bacteria (5). It has been shown that wearing a 
respirator during the three hour visit in the swine barn reduces the LPS-exposure by 
99%, measurements were performed behind the mask, and attenuates the inflammation, 
but not the increase in bronchial responsiveness in the exposed subjects (87, 88). 
Several in vitro and in vivo studies, including the first and second paper of this thesis, 
confirm these data; that dust from the swine barn was a more potent pro-inflammatory 
stimulus, then LPS and peptidoglycan (PGN) were etc. (89-91). This indicates that it 
might be other potent agents in the dust than LPS or PGN and/or several simultaneous 
occurring stimulations that will result in a synergistic immunological response.  
 
In line with the findings of attenuated TLR2 expression on blood monocytes in farmers 
(92) a lower TLR2 expression on alveolar macrophages in patients with COPD has 
been demonstrated (93). Subjects with COPD are chronically exposed to organic 
material trough inhaled tobacco smoke. In paper IV it was shown that sputum 
neutrophils have an attenuated expression of TLR2 in COPD-patients, compared to age 
matched non-smoking controls. Moreover, the concentration of soluble TLR2 (sTLR2) 
was higher in the sputum supernatant in the COPD-group compared to both the non-
smoking and smoking controls. This suggests that the receptor is probably regulated by 
shedding but also that this effect is not directly dependent of tobacco smoke exposure, 
but is more specifically involved in the patho-physiological mechanism of COPD as the 
smokers with and without COPD were matched regarding age and cumulative exposure 
to tobacco smoke. 
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Bacterial colonization in the respiratory tract is commonly occurring in farmers and 
COPD-patients; this might lead to an increased risk for exacerbations (94, 95). It seems 
likely that neutrophils exposed to a pro-inflammatory environment, induces release of 
TLR2 as a negative regulatory mechanism. The soluble form of the receptor will 
compete for the ligand with the membrane bound form of the receptor. Soluble 
receptors usually retain their ligand binding capacity and it is known that sTLR2 
attenuates the release of pro-inflammatory cytokines in monocytes that are stimulated 
with TLR2 ligands (44, 46).   
 
This reasoning is further confirmed by results from paper IV, were it was shown that 
neutrophils, at transfer from the sterile blood stream into the lungs; show a down-
regulation of TLR2 expression. This is previously shown in farmers (92) and seems to 
be a general occurring mechanism and is likely a sign of receptor shedding when 
entering a pro-inflammatory environment. Additional signs of this phenomenon are 
results from paper III, where blood neutrophils and alveolar epithelial cells have been 
co-cultured in vitro with or without pro-inflammatory stimulus. Regardless of 
endogenous or exogenous stimulation of the cells, unequivocal results showed 
significantly lower expression of TLR2 receptor. In vivo studies showed similar pattern, 
where TLR2 expression on blood neutrophils in patients with septic shock was down-
regulated compared with healthy controls (96). While the results in this thesis are 
unanimous regarding TLR2 regulation during pro-inflammatory stimulation, the 
literature on TLR2-regulation is not entirely easy to interpret, as there are several above 
all in vitro studies showing controversial results (97-99). 
 
Soluble TLR4 (sTLR4) are so far only found in human saliva and it has been shown to 
suppress LPS activation in vitro (52). It has also been shown in mice that recombinant 
sTLR4 had similar properties as sTLR2, by inhibiting the production inflammatory 
response to LPS-stimulation (50). Unlike TLR2, which appears to be down regulated 
by a pro-inflammatory environment, result from paper IV prove an up-regulation of 
TLR4 on sputum neutrophils compared with neutrophils from the blood in healthy 
controls. This pattern is also observed in farmers (92). What is clear is that different 
PRRs are differently regulated. 
 
Ex-vivo stimulation with TNF, peptidoglycan (PGN) or LPS of blood neutrophils did 
not affect the expression of TLR4 (paper III). However, during co-culture with alveolar 
epithelial cells (A549) TLR4 was significantly up-regulated independently of pro-
inflammatory stimulation. These findings are intriguing and indicate an interaction 
between epithelial cells and neutrophils, which involves regulatory mechanism of the 
signalling pathway of TLR4, irrespective of pro-inflammatory conditions. Endogenous 
TLR ligands released by epithelial cells can be of relevance in this aspect.  
 
It could be assumed that CD14 has limited opportunities to interact in the inflammatory 
host response as CD14 lacks a transmembrane domain and therefore the potential to 
initiate intracellular-signalling by itself (55). It is however known that CD14 acts as a 
pattern recognition receptor and is one of the main players involved in the signalling 
pathway of LPS via the TLR4/MD2 receptor complex. Furthermore, CD14 is 
associated with and seems to be of importance for the TLR2/TLR1 recognition of 
Pam3CSK4, although this is less studied than the co-receptor function of CD14 in the 
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TLR4 signalling pathway (100, 101). This might explain the rather weak effect of 
Pam3CSK4 stimulation on epithelial cells, observed in paper II.  
 
It has recently been found that the MyD88-independent pathway of TLR4-signaling 
requires CD14 for IFN-secretion. Moreover, murine macrophages lacking CD14, 
express the same amount of TNF upon stimulation with rough LPS as do CD14-
positive macrophages. The macrophages failed to release TNF after stimulation with 
smooth LPS, an effect that was reversed after sCD14 was added (48), indicating that 
the signaling pathway of smooth LPS is dependent of CD14. Furthermore, stimulation 
with LPS in paper II resulted in a weak response in the measured outcome variables IL-
6 and CXCL8 (IL-8). Epithelial cells are known to express very little CD14 and the 
affect on PBEC upon LPS-stimulation paper II was rather weak. But still we observed 
an increase in cytokine release as a result of stimulation, which probably was an effect 
of the CD14 independent pathway of TLR4, which bound rough LPS (rLPS).   
 
Soluble CD14 are found in serum, bronchoalveolar lavage, sputum, etc (102, 103). 
Neutrophils, monocytes and macrophages are proposed to be the main producers of 
sCD14.(104, 105) Soluble CD14 is known to increase in serum during pro-
inflammatory conditions, and is regarded as an acute phase protein. Moreover, sCD14 
are also known to be elevated in bronchoalveolar lavage (BAL) fluid from smokers 
with or without COPD. (54, 57, 58) We were not able to confirm these data in paper 
IV. A possible explanation for this discrepancy could be that smokers which are 
exposed to LPS from the tobacco smoke (106), have less unbound sCD14 in their 
supernatants. It is possible that the ligand (LPS) will compete with the antibodies of the 
ELISA through sterical or competitive inhibition, which might result in false negative 
results. The significantly lower concentration of endotoxin in BAL fluid obtained from 
smokers compared to non-smoking controls might also be explained by the occurrence 
of a sCD14/endotoxin complex.  
 
Soluble CD14 has, at least, a dualistic effect. On one hand it mediates the activation of 
CD14 negative cells or cells with very low expression of CD14, such as alveolar 
epithelial cells (107, 108). On the other hand sCD14 function as a decoy receptor, by 
competing with mCD14 for LPS and thereby reduce LPS-driven activities (109, 110). 
In paper III, communication between alveolar epithelial cells and neutrophils were 
examined. One of the main findings in that paper was that mCD14 was strongly up-
regulated on the surface on neutrophils, when co-cultured with alveolar epithelial cells, 
irrespective of pro-inflammatory activation. Moreover, the soluble form of CD14 was 
synergistically enhanced during these conditions and when LPS was added to the co-
culture CXCL8 (IL-8) and sCD14 showed an almost perfect correlation. Thus paper III 
confirms that sCD14, released by neutrophils, facilitate LPS-driven stimulation of 
epithelial cells, which in the end leads to increased CXCL8 (IL-8) production.  
 
The positive effect of inhaled steroids in patients with COPD is less beneficial than the 
effect observed in asthma in general, although the beneficial effect of steroids in severe 
asthma, often dominated by neutrophils, are less pronounced (111, 112). It has been 
shown that steroid treatment reduces the number of exacerbations and that the 
combination of an inhaled steroid and long-acting β2-agonist reduces mortality in 
COPD (30). In paper II it was demonstrated that TLR2 mRNA was synergistically 
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enhanced by budesonide on activated primary bronchial epithelial cells. This effect was 
only observed when both a pro-inflammatory stimuli and the steroid were present. This 
is regardless of whether the pro-inflammatory stimulus was endogenous (TNF) or 
exogenous (LPS, PGN). The release of the pro-inflammatory cytokines IL-6 and 
CXCL8 (IL-8) was inhibited significantly by TLR2/TLR4 antibodies, suggesting that 
the pro-inflammatory response was TLR-mediated. One possible and even probable 
explanation to the lack of difference between ligand and non-ligand stimulation, 
regarding IL-6 and CXCL8 (IL-8) secretion is, that the epithelial cells release 
endogenous TLR2 and TLR4-ligands, DAMPs, that compete with the exogenous TLR-
ligands (113). This might also explain why the release of IL-6 and CXCL8 (IL-8) was 
inhibited in un-stimulated cells with the blocking of the TLR antibodies. 
 
To conclude, research focused on regulatory mechanisms of toll-like receptors has just 
started and it is clear that the mechanisms of TLR-regulation are many and complex 
(51, 64). We have found that chronically exposed subjects have altered PRRs 
expression on cells involved in the immunological response of the host. We have also 
showed that TLR2 expression on bronchial epithelial cells increases in the presence of 
a glucocorticosteroid, a common treatment in inflammatory diseases. Last but not least 
we found a strong positive correlation between the secreted soluble CD14 and CXCL8 
(IL-8) from neutrophils and epithelial cells in co-culture during LPS-stimulation. This 
strongly suggests an up-take of sCD14 of the epithelial cells, which will facilitate the 
TLR4 signalling pathway. A better understanding of the mechanisms of chronic 
inflammation and host defence, might lead to development of new therapies that would 
potentially benefit patients with inflammatory diseases.  
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6 CONCLUSIONS 
In summary, the main results obtained from this thesis suggest the following: 
 
Paper I: 
• Individuals who are repeatedly exposed to organic material develop an 
adaptation to the effects of acute exposure to inhaled organic material. 
• Exposure to dust in the pig barn was a much stronger pro-inflammatory 
stimulus than inhalation of pure endotoxin (LPS).  
 
Paper II: 
• Exogenous stimuli (organic dust and LPS) and an endogenous stimulus (TNF) 
induced increased expression and release of IL-6 and CXCL8 (IL-8) in primary 
bronchial epithelial cells 
• TLR2 expression synergistically increases in primary bronchial epithelial cells 
by co-stimulation with pro-inflammatory stimuli and steroids. 
• Release of pro-inflammatory cytokines was attenuated by blocking of the TLR 
with monoclonal antibodies, indicating that the pro-inflammatory stimulation 
was at least partly dependent on TLR2/TLR4. 
 
Paper III: 
• Surface expression of TLR2 on neutrophils was down-regulated by pro-
inflammatory stimuli.  
• Neutrophil surface expression of membrane bound CD14 and TLR4 were 
increased when neutrophils were co-cultured with alveolar epithelial cells, 
irrespective of pro-inflammatory stimulation. 
• Soluble CD14 (sCD14) and CXCL8 were synergistically enhanced when 
neutrophils and alveolar epithelial cells were co-cultured, in vitro. Soluble 
CD14 was strongly correlated to CXCL8 release during LPS-stimulation of co-
cultured cells, whereas no such effect was observed in the absence of epithelial 
cells. This indicates an active cross-talk between A549 cells and blood 
neutrophils. 
 
Paper IV: 
• Toll-like receptor 2 expression was reduced on sputum neutrophils from 
patients with COPD compared with non-smokers, and the expression of TLR2 
on neutrophils was higher in blood than in sputum, irrespective of the presence 
of airway obstruction. 
• We show the presence of sTLR2 in sputum and BAL-fluid and that COPD was 
associated with higher levels of soluble TLR2 (sTLR2) in sputum and lower 
levels of sTLR2 in BAL-fluid compared with non-smokers.  
• The expression of CD14 on neutrophils was enhanced in sputum compared with 
blood and the gene expression of CD14 on alveolar macrophages in BAL-fluid 
was increased in smokers compared with non-smokers. 
• This indicates that pattern-recognition receptors (PRRs), are differently 
regulated in smokers with COPD compared with smokers without airflow 
limitation and non-smokers. This is likely of importance in COPD patho-
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physiology, in particular for exacerbations, which often are caused by 
microorganisms. 
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7 POPULÄRVETENSKAPLIG SAMMANFATTNING  
(IN SWEDISH) 
 
Kontinuerlig exponering för luftburna inhalerbara partiklar påverkar vårt immunförsvar 
och våra lungor. Typ av partiklar, exponeringens duration samt när i livet denna 
exponering sker, är av betydelse för konsekvenserna av exponeringen.  
 
Flertalet oberoende forskargrupper har visat att barn som växer upp på en lantgård eller 
har föräldrar som är aktiva inom jordbruksnäringen har ett visst skydd mot att utveckla 
astma och allergi. Intressant i detta avseende är att föräldrarna tycks löpa en ökad risk 
att utveckla kroniska luftvägssjukdomar t.ex. kronisk bronkit och nedsatt lungfunktion, 
jämfört med barnen. 
 
Denna avhandling fokuserar på toll-lika receptorer (TLR), en receptorfamilj som 
uttrycks av de flesta av kroppens celler, men framförallt hos de celler som är aktiva 
inom immunförsvaret. TLR2 och TLR4, två receptorer inom denna familj, binder 
bakteriefragment och startar ett immunologiskt svar. Det finns flera studier som visar 
att dessa receptorer är påverkade lokalt i lungan, men även systemiskt i blod vid 
kontinuerlig inhalation av organiska partiklar. Barn som kontinuerligt exponerats tidigt 
i livet, har ett uppreglerat TLR-receptoruttryck på cirkulerande blodceller medan 
exponerade vuxna har nedreglerat receptoruttryck på motsvarande celler. Detta skulle 
kunna medverka till den skyddande effekten gällande prevalens av astma och allergi, 
hos barn som växer upp i lantbruksmiljö. Det är också möjligt att detta bidrar till 
förklaringen att vuxna som arbetar inom lantbruk på grund av det nedreglerade 
immunsvaret har en ökad risk för sjukdomsutveckling senare i livet.  
 
Både bönder och rökare är kontinuerligt exponerade för organiskt material, bönderna 
genom sin arbetsmiljö och rökarna genom tobaksröken. Studie I visar att bönder och 
rökare har en pågående inflammation i de centrala luftvägarna och att de vid akut 
exponering i svinhuset har ett minskat immunsvar jämfört med friska kontroller. Detta 
tyder på en toleransutveckling, vilket tidigare visats hos lantbrukare. Studien visade 
även att toleransutveckling hos rökare inte sker i samma utsträckning som hos bönder.  
 
Många rökare utvecklar med tiden kroniskt obstruktiv lungsjukdom (KOL) en sjukdom 
som karaktäriseras av luftvägsobstruktion som inte normaliseras av behandling. KOL 
beror på inflammatoriska förändringar i de små perifera luftrören (bronkiolit) samt av 
emfysem i lungvävnaden. Det effektivaste sättet att stoppa denna destruktiva process är 
att avbryta den skadliga exponeringen vilket i de flesta fall innebär rökstopp.  
 
Avhandlingens andra studie fokuserar på epitelceller i luftvägarna. Epitelceller är en 
celltyp som täcker insidan av luftrören och fungerar som en barriär mellan kroppens 
inre miljö och den yttre miljön. Epitelceller är aktiva i vårt immunförsvar och uttrycker 
flera olika typer av TLR. I denna studie visar vi att steroider (inflammationshämmande 
läkemedel) ökar TLR2-uttrycket på epitelcellerna när cellerna stimulerats med 
exempelvis bakteriefragment. Dessa resultat bidrar till en ökad förståelse för TLR-
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reglering, samt kan eventuellt vara av betydelse gällande den positiva anti-
inflammatoriska effekt som erhålls vid steroidbehandling.  
 
Den tredje studien i avhandlingen studerar kommunikationen mellan alveolära 
epitelceller och neutrofila granulocyter. Avsikten med studien var att undersöka 
förekomst av aktiv kommunikation med avseende på regleringen av TLR och 
inflammatoriska markörer mellan epitelceller och neutrofiler. Vår hypotes var även att 
denna kommunikation skulle vara påverkad vid KOL. Neutrofilen är en relativt 
kortlivad cell som patrullerar vår kropp via blodbanan. Vid en infektion eller annan 
skadlig påverkan lämnar neutrofilen blodet och vandrar ut i vävnaden. Neutrofilen 
arbetar sedan aktivt med att eliminera för kroppen farliga ämnen. Resultaten från den 
tredje studien visar på att en aktiv kommunikation mellan epitelceller och neutrofiler 
pågår med avseende på uttryck av TLR och för kroppen viktiga inflammatoriska 
mediatorer. Vi kunde inte påvisa någon signifikant skillnad mellan friska kontroller och 
personer med KOL. Men vi fann ett tydligt mönster där KOL-patienterna uppvisar ett 
lägre uttryck av de studerade receptorerna. Det är troligt att skillnader mellan grupperna 
visats om materialet varit större. Resultaten i denna studie visar på en dubbelriktad 
kommunikation mellan epitelceller och neutrofiler med avseende på receptorreglering 
samt bildning och frisättning av inflammatoriska mediatorer. Förmodligen är detta 
samspel av stor relevans när det gäller kroppens försvar mot potentiellt patogena agens.   
 
I den fjärde studien har vi inkluderat kontroller samt rökare med och utan KOL. 
Målsättningen med denna studie var att studera uttryck av toll-lika receptorer från olika 
nivåer i luftvägarna, i bronkoalveolärt lavage (BAL) som speglar de nedre luftvägarna 
och sputum som representerar mer centrala luftvägar. Eftersom KOL är en 
systemsjukdom undersöktes även receptorutryck på blodceller. Vi fann dels att olika 
TLR är beroende av olika regleringsmekanismer. Vi visade även på att den lösliga 
formen av TLR2 (sTLR2) finns i BAL och sputum, något som tidigare ej har visats. 
Dessutom, skilde sig mängden av denna lösliga receptor åt mellan våra studerade 
grupper. Förutom detta visar vi på att uttrycket av TLR skiljer sig åt mellan rökare som 
har utvecklat KOL och de som inte har det. Det är troligt att detta fynd är av betydelse, 
fram för allt med tanke på att akuta mer eller mindre långvariga försämringsperioder 
(exacerbationer) ofta orsakas av bakteriella infektioner där TLR har en nyckelfunktion i 
det inflammatoriska svaret hos individen.  
 
Sammanfattningsvis visar denna avhandling att kroniskt exponerade, bönder och 
rökare, har en generell påverkan lokalt och systemiskt vad gäller det inflammatoriska 
svaret vid exponering för pro-inflammatoriska agens. Mer specifikt visas att 
regleringen av de för immunförsvaret viktiga toll-lika receptorerna är påverkade vid 
KOL och vid rökning, men även av steroider. Regleringsmekanismerna för dessa 
receptorer är många och komplexa och forskningen på detta område är i sin linda. Detta 
är ett forskningsfält som kommer att växa och vara av betydelse för framtida 
läkemedelsutveckling.    
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